Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Phosphoprotein 32 (PP32) is a tumor suppressor that can inhibit several types of cancers, including prostate and breast cancers. Zusätzlich bieten wir Ihnen ANP32C Kits (12) und ANP32C Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 60 products:
results highlight that certain malignancies with ANP32C/D overexpression or mutation might be specifically targeted using Hsp90 inhibitors.
These findings highlight that certain cancers overexpressing pp32r1 or pp32r1 mutants are likely to demonstrate enhanced resistance to FTY720 treatment.
pp32r1 binds to HuR to avoid the caspase-mediated decay of HuR in the cytoplasm of cells.
CHD4 were significantly upregulated by pp32r1 and pp32r1Y140H overexpression which influence a number of cell cycle regulator genes including p53, p21 and cyclinD1
expression levels vary among human tumor cell lines, with the highest levels found in prostatic adenocarcinoma cell lines
Phosphoprotein 32 (PP32) is a tumor suppressor that can inhibit several types of cancers, including prostate and breast cancers. The protein encoded by this gene is one of at least two proteins that are similar in amino acid sequence to PP32 and are part of the same acidic nuclear phosphoprotein gene family. However, unlike PP32, the encoded protein is tumorigenic. The tumor suppressor function of PP32 has been localized to a 25 amino acid region that is divergent between PP32 and the protein encoded by this gene. This gene does not contain introns.
acidic leucine-rich nuclear phosphoprotein 32 family member C
, phosphoprotein 32-related protein 1
, pp32 related 1
, tumorigenic protein pp32r1
, acidic (leucine-rich) nuclear phosphoprotein 32 family, member C